Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

CCND2 (Cyclin D2)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

CCND2 overexpression	Diffuse Large B Cell Lymphoma	CCND2 overexpression	Diffuse Large B Cell Lymphoma	rituximab Sensitive: C3 – Early Trials rituximab Sensitive : C3	rituximab Sensitive: C3 – Early Trials rituximab Sensitive : C3
CCND2 mutation + HR positive	HER2 Negative Breast Cancer	CCND2 mutation + HR positive	HER2 Negative Breast Cancer	palbociclib Sensitive: C3 – Early Trials palbociclib Sensitive : C3	palbociclib Sensitive: C3 – Early Trials palbociclib Sensitive : C3
CCND2 mutation	Triple Negative Breast Cancer	CCND2 mutation	Triple Negative Breast Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3